Endothelial-specific nanodelivery of Rho kinase inhibitors: Targeting tumor angiogenesis and metastasis.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology(2022)

引用 0|浏览2
暂无评分
摘要
We have successfully developed Fasudil-encapsulated, CD31-targeting liposomes. Future studies will be directed to study the formulation's effect on endothelial physiology in vitro and in vivo, tumor growth, angiogenesis, and metastasis.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要